192 related articles for article (PubMed ID: 35758181)
41. Clostridium difficile infection in patients with inflammatory bowel disease: a case control study.
Vitikainen K; Haapamäki J; Färkkilä M; Anttila VJ; Arkkila P
Scand J Gastroenterol; 2018 Aug; 53(8):947-951. PubMed ID: 30041549
[TBL] [Abstract][Full Text] [Related]
42. Inflammatory Bowel Disease Affects the Outcome of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection.
Khoruts A; Rank KM; Newman KM; Viskocil K; Vaughn BP; Hamilton MJ; Sadowsky MJ
Clin Gastroenterol Hepatol; 2016 Oct; 14(10):1433-8. PubMed ID: 26905904
[TBL] [Abstract][Full Text] [Related]
43. Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease.
Ananthakrishnan AN; McGinley EL; Binion DG
Gut; 2008 Feb; 57(2):205-10. PubMed ID: 17905821
[TBL] [Abstract][Full Text] [Related]
44. Host Sorbitol and Bacterial Sorbitol Utilization Promote Clostridioides difficile Infection in Inflammatory Bowel Disease.
Yang Z; Qin J; Zhao L; Chen T; Huang Q; Jian Y; Zhao Q; Yang S; Li Q; Liu Q; Otto M; Li M
Gastroenterology; 2023 Jun; 164(7):1189-1201.e13. PubMed ID: 36898551
[TBL] [Abstract][Full Text] [Related]
45. Proton pump Inhibitors and Risk of Enteric Infection in Inflammatory Bowel Disease: A Self-controlled Case Series.
Varma S; Trudeau SJ; Li J; Freedberg DE
Inflamm Bowel Dis; 2024 Jan; 30(1):38-44. PubMed ID: 36917215
[TBL] [Abstract][Full Text] [Related]
46. Risk Factors for Clostridium difficile Isolation in Inflammatory Bowel Disease: A Prospective Study.
Micic D; Yarur A; Gonsalves A; Rao VL; Broadaway S; Cohen R; Dalal S; Gaetano JN; Glick LR; Hirsch A; Pekow J; Sakuraba A; Walk ST; Rubin DT
Dig Dis Sci; 2018 Apr; 63(4):1016-1024. PubMed ID: 29417331
[TBL] [Abstract][Full Text] [Related]
47. Non-Clostridium difficile Bacterial Infections Are Rare in Patients With Flares of Inflammatory Bowel Disease.
Hanada Y; Khanna S; Loftus EV; Raffals LE; Pardi DS
Clin Gastroenterol Hepatol; 2018 Apr; 16(4):528-533. PubMed ID: 29037938
[TBL] [Abstract][Full Text] [Related]
48. Low risk of Clostridium difficile infections in hospitalized patients with inflammatory bowel disease in a German tertiary referral center.
Ott C; Girlich C; Klebl F; Plentz A; Iesalnieks I; Schölmerich J; Obermeier F
Digestion; 2011; 84(3):187-92. PubMed ID: 21646782
[TBL] [Abstract][Full Text] [Related]
49. High incidence and morbidity of Clostridium difficile infection among hospitalized patients with inflammatory bowel disease: A prospective observational cohort study.
Chen XL; Deng J; Chen X; Wan SS; Wang Y; Cao Q
J Dig Dis; 2019 Sep; 20(9):460-466. PubMed ID: 31278840
[TBL] [Abstract][Full Text] [Related]
50. MICROBIOTA INSIGHTS IN CLOSTRIDIUM DIFFICILE INFECTION AND INFLAMMATORY BOWEL DISEASE.
Rodríguez C; Romero E; Garrido-Sanchez L; Alcaín-Martínez G; Andrade RJ; Taminiau B; Daube G; García-Fuentes E
Gut Microbes; 2020 Nov; 12(1):1725220. PubMed ID: 32129694
[TBL] [Abstract][Full Text] [Related]
51. Clostridium difficile and inflammatory bowel disease: role in pathogenesis and implications in treatment.
Nitzan O; Elias M; Chazan B; Raz R; Saliba W
World J Gastroenterol; 2013 Nov; 19(43):7577-85. PubMed ID: 24282348
[TBL] [Abstract][Full Text] [Related]
52.
Bolukcu S; Hakyemez IN; Gultepe BS; Okay G; Durdu B; Koc MM; Aslan T
Saudi J Gastroenterol; 2019; 25(6):384-389. PubMed ID: 31793457
[TBL] [Abstract][Full Text] [Related]
53. Clostridium difficile infection in newly diagnosed pediatric inflammatory bowel disease in the mid-southern United States.
Mir SA; Kellermayer R
J Pediatr Gastroenterol Nutr; 2013 Oct; 57(4):487-8. PubMed ID: 23783013
[TBL] [Abstract][Full Text] [Related]
54. Blastocystis and Clostridioides difficile: Evidence for a Synergistic Role in Colonization Among IBD Patients with Emphasis on Ulcerative Colitis.
Azimirad M; Gol SMA; Javanmard E; Mirjalali H; Yadegar A; Aghdaei HA; Shahrokh S; Balaii H; Sadeghi A; Zali MR
Turk J Gastroenterol; 2021 Jun; 32(6):500-507. PubMed ID: 34405816
[TBL] [Abstract][Full Text] [Related]
55. Prevalence and risk factors of Clostridium difficile infection in patients hospitalized for flare of inflammatory bowel disease: a retrospective assessment.
Regnault H; Bourrier A; Lalande V; Nion-Larmurier I; Sokol H; Seksik P; Barbut F; Cosnes J; Beaugerie L
Dig Liver Dis; 2014 Dec; 46(12):1086-92. PubMed ID: 25294795
[TBL] [Abstract][Full Text] [Related]
56. Host Immune Response to Clostridium difficile Infection in Inflammatory Bowel Disease Patients.
Hughes M; Qazi T; Berg A; Weinberg J; Chen X; Kelly CP; Farraye FA
Inflamm Bowel Dis; 2016 Apr; 22(4):853-61. PubMed ID: 26954708
[TBL] [Abstract][Full Text] [Related]
57. Risk factors and clinical outcome of Clostridium difficile infection in patients with IBD: A single-center retrospective study of 260 cases in China.
Gu YB; Zhang MC; Sun J; Lv KZ; Zhong J
J Dig Dis; 2017 Apr; 18(4):207-211. PubMed ID: 28251812
[TBL] [Abstract][Full Text] [Related]
58. Higher plasma vitamin D is associated with reduced risk of Clostridium difficile infection in patients with inflammatory bowel diseases.
Ananthakrishnan AN; Cagan A; Gainer VS; Cheng SC; Cai T; Szolovits P; Shaw SY; Churchill S; Karlson EW; Murphy SN; Kohane I; Liao KP
Aliment Pharmacol Ther; 2014 May; 39(10):1136-42. PubMed ID: 24641590
[TBL] [Abstract][Full Text] [Related]
59. Long-Duration Oral Vancomycin to Treat Clostridioides difficile in Patients With Inflammatory Bowel Disease Is Associated With a Low Rate of Recurrence.
Lei DK; Ollech JE; Andersen M; Weisshof R; Zmeter N; Sossenheimer P; Rubin DT
Am J Gastroenterol; 2019 Dec; 114(12):1904-1908. PubMed ID: 31714359
[TBL] [Abstract][Full Text] [Related]
60. The Elevated Risk of Recurrent Clostridioides Difficile Infection in Patients with Inflammatory Bowel Disease: a Systematic Review and Meta-analysis.
Yang X; Huang Z; He J; Chen Y
Clin Lab; 2021 May; 67(5):. PubMed ID: 33978386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
